Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30067529HIVENSG00000070669.17protein_codingASNSNoNo440P08243
TVIS30067530HIVENSG00000070669.17protein_codingASNSNoNo440P08243
TVIS20001909HPVENSG00000070669.17protein_codingASNSNoNo440P08243
TVIS44007056HTLV-1ENSG00000070669.17protein_codingASNSNoNo440P08243
TCGA Plot Options
Drug Information
GeneASNS
DrugBank IDDB00128
Drug NameAspartic acid
Target IDBE0000219
UniProt IDP08243
Regulation Typesubstrate
PubMed IDs27251594
CitationsYu Q, Wang X, Wang L, Zheng J, Wang J, Wang B: Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells. Scand J Gastroenterol. 2016 Oct;51(10):1220-6. doi: 10.1080/00365521.2016.1190399. Epub 2016 Jun 2.
GroupsApproved; Nutraceutical
Direct ClassificationAspartic acid and derivatives
SMILESN[C@@H](CC(O)=O)C(O)=O
PathwaysLesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Xanthinuria Type I; Hyperornithinemia with Gyrate Atrophy (HOGA); Purine Nucleoside Phosphorylase Deficiency; Carnosinuria, Carnosinemia; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; Argininosuccinic Aciduria; L-Arginine:Glycine Amidinotransferase Deficiency; Xanthine Dehydrogenase Deficiency (Xanthinuria); Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Mitochondrial DNA Depletion Syndrome; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Myoadenylate Deaminase Deficiency; Homocarnosinosis; Malate-Aspartate Shuttle; Arginine and Proline Metabolism; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Adenylosuccinate Lyase Deficiency; Ammonia Recycling
PharmGKBPA448494
ChEMBLCHEMBL274323